BLISS GVS PHARMA
Back to Cashflow Statement
|
BLISS GVS PHARMA Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-30 Cr | ₹-21 Cr | ₹-25 Cr | ₹-24 Cr | ₹-21 Cr |
What is the latest Cash Flow from Financing Activities ratio of BLISS GVS PHARMA ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-30 Cr |
| Mar2024 | ₹-21 Cr |
| Mar2023 | ₹-25 Cr |
| Mar2022 | ₹-24 Cr |
| Mar2021 | ₹-21 Cr |
How is Cash Flow from Financing Activities of BLISS GVS PHARMA Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-30 Cr | Negative | |
| Mar2024 | ₹-21 Cr | Negative | |
| Mar2023 | ₹-25 Cr | Negative | |
| Mar2022 | ₹-24 Cr | Negative | |
| Mar2021 | ₹-21 Cr | - | |
Compare Cash Flow from Financing Activities of peers of BLISS GVS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BLISS GVS PHARMA | ₹1,757.3 Cr | 3.7% | 9% | 26% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹439,378.0 Cr | 1.7% | 7.3% | 0% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,996.0 Cr | 1.8% | 0.9% | 6.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹125,959.0 Cr | 1.3% | 4.4% | 14.9% | Stock Analytics | |
| CIPLA | ₹123,666.0 Cr | 0.9% | -2.9% | 1.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,008.0 Cr | 0.5% | -3.1% | 3.3% | Stock Analytics | |
BLISS GVS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BLISS GVS PHARMA | 3.7% |
9% |
26% |
| SENSEX | 0.6% |
1.3% |
7% |
You may also like the below Video Courses